Renal clearance of quantum dots

被引:3504
作者
Choi, Hak Soo
Liu, Wenhao
Misra, Preeti
Tanaka, Eiichi
Zimmer, John P.
Ipe, Binil Itty
Bawendi, Moungi G.
Frangioni, John V.
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
[3] MIT, Dept Chem, Cambridge, MA 02139 USA
关键词
D O I
10.1038/nbt1340
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The field of nanotechnology holds great promise for the diagnosis and treatment of human disease. However, the size and charge of most nanoparticles preclude their efficient clearance from the body as intact nanoparticles. Without such clearance or their biodegradation into biologically benign components, toxicity is potentially amplified and radiological imaging is hindered. Using intravenously administered quantum dots in rodents as a model system, we have precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles. Zwitterionic or neutral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic diameter by > 15 nm and prevented renal excretion. A final hydrodynamic diameter <5.5 nm resulted in rapid and efficient urinary excretion and elimination of quantum dots from the body. This study provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 24 条
  • [1] Sentinel lymph node imaging using quantum dots in mouse tumor models
    Ballou, Byron
    Ernst, Lauren A.
    Andreko, Susan
    Harper, Theresa
    Fitzpatrick, James A. J.
    Waggoner, Alan S.
    Bruchez, Marcel P.
    [J]. BIOCONJUGATE CHEMISTRY, 2007, 18 (02) : 389 - 396
  • [2] Serum test for assessment of patients with Bence Jones myeloma
    Bradwell, AR
    Carr-Smith, HD
    Mead, GP
    Harvey, TC
    Drayson, MT
    [J]. LANCET, 2003, 361 (9356) : 489 - 491
  • [3] Therapeutic antibody fragments with prolonged in vivo half-lives
    Chapman, AP
    Antoniw, P
    Spitali, M
    West, S
    Stephens, S
    King, DJ
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (08) : 780 - 783
  • [4] (CdSe)ZnS core-shell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites
    Dabbousi, BO
    RodriguezViejo, J
    Mikulec, FV
    Heine, JR
    Mattoussi, H
    Ober, R
    Jensen, KF
    Bawendi, MG
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 1997, 101 (46) : 9463 - 9475
  • [5] An operational near-infrared fluorescence imaging system prototype for large animal surgery
    De Grand, AM
    Frangioni, JV
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2003, 2 (06) : 553 - 562
  • [6] Emission intensity dependence and single-exponential behavior in single colloidal quantum dot fluorescence lifetimes
    Fisher, BR
    Eisler, HJ
    Stott, NE
    Bawendi, MG
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 2004, 108 (01) : 143 - 148
  • [7] Frangioni John V, 2007, Methods Mol Biol, V374, P147
  • [8] Semiconductor quantum rods as single molecule fluorescent biological labels
    Fu, Aihua
    Gu, Weiwei
    Boussert, Benjamin
    Koski, Kristie
    Gerion, Daniele
    Manna, Liberato
    Le Gros, Mark
    Larabell, Carolyn A.
    Alivisatos, A. Paul
    [J]. NANO LETTERS, 2007, 7 (01) : 179 - 182
  • [9] Goel A, 2000, CANCER RES, V60, P6964
  • [10] LYSOZYME TURNOVER IN RAT
    HANSEN, NE
    KARLE, H
    ANDERSEN, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (07) : 1473 - &